Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 8sanofi-aventis Canada Inc.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2013-11-08
Date Granted : 2003-01-07
Brand Name : TAXOTERE
Patent Number : 2149055
Filing Date : 1993-11-08
Strength per Unit : 20 mg / 0.5 ml
Dosage Form : Injectable
Human Or VET : Human
Route of Administration : Intravenous Infusion
Patent Expiration Date : 2013-11-08
Date Granted : 2003-01-07
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2012-07-03
Date Granted : 2004-09-07
Brand Name : TAXOTERE
Patent Number : 2102777
Filing Date : 1992-07-03
Strength per Unit : 20 mg / 0.5 ml
Dosage Form : Injectable
Human Or VET : Human
Route of Administration : Intravenous Infusion
Patent Expiration Date : 2012-07-03
Date Granted : 2004-09-07
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2013-11-08
Date Granted : 2003-01-07
Brand Name : TAXOTERE
Patent Number : 2149055
Filing Date : 1993-11-08
Strength per Unit : 80 mg / 2 ml
Dosage Form : Injectable
Human Or VET : Human
Route of Administration : Intravenous Infusion
Patent Expiration Date : 2013-11-08
Date Granted : 2003-01-07
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2012-07-03
Date Granted : 2004-09-07
Brand Name : TAXOTERE
Patent Number : 2102777
Filing Date : 1992-07-03
Strength per Unit : 80 mg / 2 ml
Dosage Form : Injectable
Human Or VET : Human
Route of Administration : Intravenous Infusion
Patent Expiration Date : 2012-07-03
Date Granted : 2004-09-07
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2013-11-26
Date Granted : 2005-06-21
Brand Name : TAXOTERE
Patent Number : 2150576
Filing Date : 1993-11-26
Strength per Unit : 20 mg / 0.5 ml
Dosage Form : Injectable
Human Or VET : Human
Route of Administration : Intravenous Infusion
Patent Expiration Date : 2013-11-26
Date Granted : 2005-06-21
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2012-07-03
Date Granted : 2004-04-20
Brand Name : TAXOTERE
Patent Number : 2102778
Filing Date : 1992-07-03
Strength per Unit : 20 mg / 0.5 ml
Dosage Form : Injectable
Human Or VET : Human
Route of Administration : Intravenous Infusion
Patent Expiration Date : 2012-07-03
Date Granted : 2004-04-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2013-11-26
Date Granted : 2005-06-21
Brand Name : TAXOTERE
Patent Number : 2150576
Filing Date : 1993-11-26
Strength per Unit : 80 mg / 2 ml
Dosage Form : Injectable
Human Or VET : Human
Route of Administration : Intravenous Infusion
Patent Expiration Date : 2013-11-26
Date Granted : 2005-06-21
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2012-07-03
Date Granted : 2004-04-20
Brand Name : TAXOTERE
Patent Number : 2102778
Filing Date : 1992-07-03
Strength per Unit : 80 mg / 2 ml
Dosage Form : Injectable
Human Or VET : Human
Route of Administration : Intravenous Infusion
Patent Expiration Date : 2012-07-03
Date Granted : 2004-04-20
